Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM2 | Q00987 | 1/20 | 0.48 |
| ▸ | CES1 | P23141 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | CES2 | O00748 | 2/20 | 0.47 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.44 |
| ▸ | PGR | P06401 | 1/20 | 0.44 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.44 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
| ▸ | HRH1 | P35367 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL2353850 | 0.98 | MDM2 (0.47) | MDM2CES1LMNACES2ALKBH5 | |
| Hydrochloric Acid SCHEMBL2356480 | 0.98 | MDM2 (0.47) | MDM2CES1LMNACES2ALKBH5 | |
| Bromide SCHEMBL2356766 | 0.98 | MDM2 (0.47) | MDM2CES1LMNACES2ALKBH5 | |
| Water SCHEMBL16320768 | 0.98 | MDM2 (0.47) | MDM2CES1LMNACES2ALKBH5 | |
| SCHEMBL5144207 | 0.83 | LMNA (0.44) | LMNAPGRADRA2AADRA2BHTR2A | |
| Iodide SCHEMBL11214733 | 0.81 | LMNA (0.42) | LMNATDP1L3MBTL1MAPTNPC1 | |
| SCHEMBL11020500 | 0.81 | CA12 (0.46) | MAPTCHRM2CHRM1CHRM3CA12 | |
| Iodide SCHEMBL10522536 | 0.80 | CES2 (0.49) | CES1CES2TDP1MAPTMAPK1 | |
| SCHEMBL11122619 | 0.79 | ALDH1A1 (0.49) | CES1LMNACES2HTTKMT2A | |
| SCHEMBL11230342 | 0.79 | ALDH1A1 (0.51) | TDP1MAPTMAPK1NPC1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119215983-A | Quaternary ammonium salt ionic liquid catalyst for synthesizing diether fluorene and preparation method thereof | 濮阳市盛通聚源新材料有限公司 | 2024-12-31 | — | — | CN | claimed |
| WO-2024196901-A2 | A HIGH THROUGHPUT ION-SENSING METHOD | WHITESIDES GEORGE M (US) | 2024-09-26 | — | — | WO | claimed |
| EP-3123860-B1 | ACELLULAR COLLAGENOUS TISSUE AND PROCESSING METHOD OF ARTIFICIAL VALVE COMPRISING ACELLULAR COLLAGENOUS TISSUE | KINGSTRONBIO CHANGSHU CO LTD (CN) | 2020-02-12 | — | — | EP | claimed |
| CN-104023526-B | A kind ofly process the method for biomaterial and the biomaterial through the method process | KINGSTRONBIO (CHANGSHU) Co.,Ltd. (CN) | 2016-01-13 | — | — | CN | claimed |
| CN-104023526-A | Biological material processing method, and biological material processed through the same | JINSHI BIOTECHNOLOGY CHANGSHU CO LTD | 2014-09-03 | — | — | CN | claimed |
| CN-101058745-B | Removal and recovery of naphthenic acid in oil based on ion switch principle | INST PROCESS ENG CAS | 2011-09-07 | — | — | CN | claimed |
| CN-101260051-A | Biodegradable choline-like ionic liquid | INST PROCESS ENG CAS (CN) | 2008-09-10 | — | — | CN | claimed |
| CN-101058745-A | Removal and recovery of naphthenic acid in oil based on ion switch principle | INST PROCESS ENG CAS (CN) | 2007-10-24 | — | — | CN | claimed |
| CN-101050185-A | Ion liquid of quaternaries of naphthenic acid | INST OF PROCEDUE ENGINEERING C (CN) | 2007-10-10 | — | — | CN | claimed |
| US-20050232864-A1 | Method for phenotyping using nmr spectroscopy | OXFORD INSTRUMENTS MOLECULAR BIOTOOLS LIMITED (GB) | 2005-10-20 | — | — | US | claimed |
| US-20050233470-A1 | Methods and compound mixtures for determining protein activity using nmr spectroscopy | OXFORD INSTRUMENTS MOLECULAR BIOTOOLS LIMITED (GB) | 2005-10-20 | — | — | US | claimed |
| EP-1501940-A1 | METHOD FOR PHENOTYPING USING NMR SPECTROSCOPY | Amersham Health AS (NO) | 2005-02-02 | — | — | EP | claimed |
| EP-1497448-A1 | METHODS AND COMPOUND MIXTURES FOR DETERMINING PROTEIN ACTIVITY USING NMR SPECTROSCOPY | Amersham Health AS (NO) | 2005-01-19 | — | — | EP | claimed |
| WO-2003089656-A1 | METHODS AND COMPOUND MIXTURES FOR DETERMINING PROTEIN ACTIVITY USING NMR SPECTROSCOPY | AMERSHAM HEALTH AS (NO) | 2003-10-30 | — | — | WO | claimed |
| WO-2003089657-A1 | METHOD FOR PHENOTYPING USING NMR SPECTROSCOPY | AMERSHAM HEALTH AS (NO) | 2003-10-30 | — | — | WO | claimed |
| EP-0657545-B1 | Assay method for biological components | DAIICHI PURE CHEMICALS CO LTD (JP) | 2003-08-06 | — | — | EP | claimed |
| EP-0674232-B1 | Recording sheets | XEROX CORP (US) | 2000-05-31 | — | — | EP | claimed |
| EP-0674233-B1 | Recording sheets | XEROX CORP (US) | 2000-05-24 | — | — | EP | claimed |
| US-5559003-A | BILIRUBIN INTERFERENCE | DAIICHI PURE CHEMICALS CO., LTD. (JP) | 1996-09-24 | — | — | US | claimed |
| US-4135980-A | PREPARATION BY CULTURING MICROORGANISM OF GENUS ARTHROBACTER, USE IN DETERMINATION OF CHOLINE OR BETAINE ALDEHYDE | TOYO JOZO KABUSHIKI KAISHA (JP) | 1979-01-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050232864-A1 | Method for phenotyping using nmr spectroscopy | TSPO, FABP3, HNRNPA3 | MDM2 1734/4885CES1 159/4885LMNA 1468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.